Cargando…

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas

Detalles Bibliográficos
Autores principales: Wang, Congxiao, Liu, Shifeng, Peng, Lijing, Zhang, Kaixian, Li, Wei, Zhang, Hao, Luan, Ying, Li, Peishun, Hu, Xiaokun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412639/
https://www.ncbi.nlm.nih.gov/pubmed/32767991
http://dx.doi.org/10.1186/s12885-020-07246-w
_version_ 1783568651375345664
author Wang, Congxiao
Liu, Shifeng
Peng, Lijing
Zhang, Kaixian
Li, Wei
Zhang, Hao
Luan, Ying
Li, Peishun
Hu, Xiaokun
author_facet Wang, Congxiao
Liu, Shifeng
Peng, Lijing
Zhang, Kaixian
Li, Wei
Zhang, Hao
Luan, Ying
Li, Peishun
Hu, Xiaokun
author_sort Wang, Congxiao
collection PubMed
description
format Online
Article
Text
id pubmed-7412639
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74126392020-08-10 Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas Wang, Congxiao Liu, Shifeng Peng, Lijing Zhang, Kaixian Li, Wei Zhang, Hao Luan, Ying Li, Peishun Hu, Xiaokun BMC Cancer Correction BioMed Central 2020-08-07 /pmc/articles/PMC7412639/ /pubmed/32767991 http://dx.doi.org/10.1186/s12885-020-07246-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Wang, Congxiao
Liu, Shifeng
Peng, Lijing
Zhang, Kaixian
Li, Wei
Zhang, Hao
Luan, Ying
Li, Peishun
Hu, Xiaokun
Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
title Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
title_full Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
title_fullStr Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
title_full_unstemmed Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
title_short Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
title_sort correction to: permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412639/
https://www.ncbi.nlm.nih.gov/pubmed/32767991
http://dx.doi.org/10.1186/s12885-020-07246-w
work_keys_str_mv AT wangcongxiao correctiontopermanentiodine125brachytherapyforpatientswithprogressiveorrecurrenthighgradegliomas
AT liushifeng correctiontopermanentiodine125brachytherapyforpatientswithprogressiveorrecurrenthighgradegliomas
AT penglijing correctiontopermanentiodine125brachytherapyforpatientswithprogressiveorrecurrenthighgradegliomas
AT zhangkaixian correctiontopermanentiodine125brachytherapyforpatientswithprogressiveorrecurrenthighgradegliomas
AT liwei correctiontopermanentiodine125brachytherapyforpatientswithprogressiveorrecurrenthighgradegliomas
AT zhanghao correctiontopermanentiodine125brachytherapyforpatientswithprogressiveorrecurrenthighgradegliomas
AT luanying correctiontopermanentiodine125brachytherapyforpatientswithprogressiveorrecurrenthighgradegliomas
AT lipeishun correctiontopermanentiodine125brachytherapyforpatientswithprogressiveorrecurrenthighgradegliomas
AT huxiaokun correctiontopermanentiodine125brachytherapyforpatientswithprogressiveorrecurrenthighgradegliomas